Borisov N - Search Results

1

Molecular Pathway Analysis of Mutation Data for Biomarkers Discovery and Scoring of Target Cancer Drugs.

Zolotovskaia M, Sorokin M, Garazha A, Borisov N, Buzdin A. Zolotovskaia M, et al. Among authors: borisov n. Methods Mol Biol. 2020;2063:207-234. doi: 10.1007/978-1-0716-0138-9_16. Methods Mol Biol. 2020. PMID: 31667773

2

Mathematical Justification of Expression-Based Pathway Activation Scoring (PAS).

Aliper AM, Korzinkin MB, Kuzmina NB, Zenin AA, Venkova LS, Smirnov PY, Zhavoronkov AA, Buzdin AA, Borisov NM. Aliper AM, et al. Methods Mol Biol. 2017;1613:31-51. doi: 10.1007/978-1-4939-7027-8_3. Methods Mol Biol. 2017. PMID: 28849557

3

Bioinformatics Meets Biomedicine: OncoFinder, a Quantitative Approach for Interrogating Molecular Pathways Using Gene Expression Data.

Buzdin AA, Prassolov V, Zhavoronkov AA, Borisov NM. Buzdin AA, et al. Methods Mol Biol. 2017;1613:53-83. doi: 10.1007/978-1-4939-7027-8_4. Methods Mol Biol. 2017. PMID: 28849558

4

Pathway Instability Is an Effective New Mutation-Based Type of Cancer Biomarkers.

Zolotovskaia MA, Sorokin MI, Roumiantsev SA, Borisov NM, Buzdin AA. Zolotovskaia MA, et al. Front Oncol. 2019 Jan 4;8:658. doi: 10.3389/fonc.2018.00658. eCollection 2018. Front Oncol. 2019. PMID: 30662873 Free PMC article.

5

Pathway Based Analysis of Mutation Data Is Efficient for Scoring Target Cancer Drugs.

Zolotovskaia MA, Sorokin MI, Emelianova AA, Borisov NM, Kuzmin DV, Borger P, Garazha AV, Buzdin AA. Zolotovskaia MA, et al. Front Pharmacol. 2019 Jan 23;10:1. doi: 10.3389/fphar.2019.00001. eCollection 2019. Front Pharmacol. 2019. PMID: 30728774 Free PMC article.

6

Novel robust biomarkers for human bladder cancer based on activation of intracellular signaling pathways.

Lezhnina K, Kovalchuk O, Zhavoronkov AA, Korzinkin MB, Zabolotneva AA, Shegay PV, Sokov DG, Gaifullin NM, Rusakov IG, Aliper AM, Roumiantsev SA, Alekseev BY, Borisov NM, Buzdin AA. Lezhnina K, et al. Oncotarget. 2014 Oct 15;5(19):9022-32. doi: 10.18632/oncotarget.2493. Oncotarget. 2014. PMID: 25296972 Free PMC article.

7

Early stage of cytomegalovirus infection suppresses host microRNA expression regulation in human fibroblasts.

Buzdin AA, Artcibasova AV, Fedorova NF, Suntsova MV, Garazha AV, Sorokin MI, Allina D, Shalatonin M, Borisov NM, Zhavoronkov AA, Kovalchuk I, Kovalchuk O, Kushch AA. Buzdin AA, et al. Cell Cycle. 2016 Dec 16;15(24):3378-3389. doi: 10.1080/15384101.2016.1241928. Cell Cycle. 2016. PMID: 28051642 Free PMC article.

8

Signaling pathway cloud regulation for in silico screening and ranking of the potential geroprotective drugs.

Zhavoronkov A, Buzdin AA, Garazha AV, Borisov NM, Moskalev AA. Zhavoronkov A, et al. Front Genet. 2014 Mar 3;5:49. doi: 10.3389/fgene.2014.00049. eCollection 2014. Front Genet. 2014. PMID: 24624136 Free PMC article.

9

MiRImpact, a new bioinformatic method using complete microRNA expression profiles to assess their overall influence on the activity of intracellular molecular pathways.

Artcibasova AV, Korzinkin MB, Sorokin MI, Shegay PV, Zhavoronkov AA, Gaifullin N, Alekseev BY, Vorobyev NV, Kuzmin DV, Kaprin АD, Borisov NM, Buzdin AA. Artcibasova AV, et al. Among authors: borisov nm. Cell Cycle. 2016;15(5):689-98. doi: 10.1080/15384101.2016.1147633. Cell Cycle. 2016. PMID: 27027999 Free PMC article.

10

Oncofinder, a new method for the analysis of intracellular signaling pathway activation using transcriptomic data.

Buzdin AA, Zhavoronkov AA, Korzinkin MB, Venkova LS, Zenin AA, Smirnov PY, Borisov NM. Buzdin AA, et al. Front Genet. 2014 Mar 25;5:55. doi: 10.3389/fgene.2014.00055. eCollection 2014. Front Genet. 2014. PMID: 24723936 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters